Safety and Efficacy Findings from the Open-Label, Multicenter, Phase 3B, Expanded Treatment Protocol Study of Ruxolitinib for Treatment of Patients with Polycythemia Vera Who Are Resistant/Intolerant to Hydroxyurea and for Whom No Alternative Treatments Are Available

AuthID
P-00R-J33
14
Author(s)
Foltz, L
·
Pica, GM
·
Zerazhi, H
·
Van Droogenbroeck, J
·
Visanica, S
·
de la Fuente, EB
·
Leber, B
·
Ranta, D
·
Kiladjian, JJ
·
Chrit, L
·
Kandra, A
·
Morando, J
·
Devos, T
Document Type
Article
Year published
2019
Published
in LEUKEMIA & LYMPHOMA, ISSN: 1042-8194
Volume: 60, Issue: 14, Pages: 3493-3502 (10)
Indexing
Publication Identifiers
Pubmed: 31359808
Scopus: 2-s2.0-85077097704
Wos: WOS:000479548900001
Source Identifiers
ISSN: 1042-8194
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.